MacroGenics, Inc. (MGNX)
NASDAQ: MGNX · Real-Time Price · USD
1.520
+0.030 (2.01%)
Jul 16, 2025, 4:00 PM - Market closed
MacroGenics Revenue
MacroGenics had revenue of $13.19M in the quarter ending March 31, 2025, with 44.90% growth. This brings the company's revenue in the last twelve months to $154.05M, up 255.31% year-over-year. In the year 2024, MacroGenics had annual revenue of $149.96M with 155.26% growth.
Revenue (ttm)
$154.05M
Revenue Growth
+255.31%
P/S Ratio
0.62
Revenue / Employee
$451,760
Employees
341
Market Cap
95.90M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 149.96M | 91.21M | 155.26% |
| Dec 31, 2023 | 58.75M | -93.19M | -61.33% |
| Dec 31, 2022 | 151.94M | 74.49M | 96.19% |
| Dec 31, 2021 | 77.45M | -27.44M | -26.16% |
| Dec 31, 2020 | 104.88M | 40.70M | 63.40% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 410.06B |
| Johnson & Johnson | 89.33B |
| Merck & Co. | 63.92B |
| AbbVie | 57.37B |
| AstraZeneca | 54.98B |
| Novartis AG | 53.22B |
| Eli Lilly and Company | 49.00B |
| Novo Nordisk | 43.92B |
MGNX News
- 5 weeks ago - MacroGenics: Working On That Road To Recovery - Seeking Alpha
- 5 weeks ago - MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement - GlobeNewsWire
- 6 weeks ago - MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025 - GlobeNewsWire
- 2 months ago - MacroGenics Provides Update on Corporate Progress and First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - MacroGenics Announces Date of First Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - MacroGenics to Participate in Upcoming Investor Conference - GlobeNewsWire
- 4 months ago - MacroGenics, Inc. (MGNX) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 4 months ago - MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call - GlobeNewsWire